We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZLTQ
876
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $302K | ﹤0.01% |
+19,885
| New | +$340K |
|
877
ResMed
RMD
$30.2B
| $295K | ﹤0.01% |
5,835
-19,154
| -77% | -$949K |
|
878
Workday
WDAY
$44.2B
| $295K | ﹤0.01% |
+3,287
| New | +$259K |
|
879
Enovis
ENOV
$1.51B
| $294K | ﹤0.01% |
+2,290
| New | +$286K |
|
880
Portland General Electric
POR
$5.8B
| $292K | ﹤0.01% |
8,415
-92,621
| -92% | -$3.05M |
|
881
CRH
CRH
$66.9B
| $287K | ﹤0.01% |
+11,105
| New | +$314K |
|
882
Open Text
OTEX
$5.94B
| $287K | ﹤0.01% |
11,932
-1,135,546
| -99% | -$26.9M |
|
|
CUK
883
DELISTED
Carnival PLC
CUK
| $284K | ﹤0.01% |
7,493
-22,728
| -75% | -$897K |
|
884
Knowles
KN
$3.32B
| $284K | ﹤0.01% |
+9,238
| New | +$279K |
|
|
ATHL
885
DELISTED
ATHLON ENERGY INC COM
ATHL
| $284K | ﹤0.01% |
+5,958
| New | +$250K |
|
|
SGMO
886
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $280K | ﹤0.01% |
+18,329
| New | +$264K |
|
887
Patrick Industries
PATK
$2.92B
| $279K | ﹤0.01% |
20,216
-13,146
| -39% | -$158K |
|
|
ATSG
888
DELISTED
Air Transport Services Group
ATSG
| $277K | ﹤0.01% |
33,038
-26,864
| -45% | -$227K |
|
889
Central Garden & Pet Co
CENT
$2.79B
| $276K | ﹤0.01% |
37,949
| – | – |
|
890
CTS Corp
CTS
$1.9B
| $270K | ﹤0.01% |
+14,439
| New | +$266K |
|
891
Kaiser Aluminum
KALU
$3B
| $270K | ﹤0.01% |
+3,701
| New | +$262K |
|
892
Nektar Therapeutics
NKTR
$2.55B
| $268K | ﹤0.01% |
+1,394
| New | +$247K |
|
893
Trimble
TRMB
$13.8B
| $268K | ﹤0.01% |
7,246
-1,767
| -20% | -$66.1K |
|
|
KG
894
Kestrel Group
KG
$69.6M
| $267K | ﹤0.01% |
+1,105
| New | +$269K |
|
|
NWLIA
895
DELISTED
NATL WESTN LIFE INS CO CL A
NWLIA
| $267K | ﹤0.01% |
1,070
| – | – |
|
|
IGTE
896
DELISTED
IGATE CORPORATION
IGTE
| $265K | ﹤0.01% |
+7,286
| New | +$255K |
|
|
LADR
897
Ladder Capital
LADR
$1.24B
| $264K | ﹤0.01% |
+18,204
| New | +$268K |
|
898
Vishay Precision Group
VPG
$926M
| $254K | ﹤0.01% |
15,451
-553
| -3% | -$9.05K |
|
|
SEAC
899
DELISTED
Seachange International Inc
SEAC
| $254K | ﹤0.01% |
1,582
-2,947
| -65% | -$541K |
|
900
CBRE Group
CBRE
$43.5B
| $253K | ﹤0.01% |
+7,900
| New | +$228K |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.